Comparative analysis of the addition of empagliflozin versus doubling the furosemide dose in decompensated heart failure.

Saved in:
Bibliographic Details
Title: Comparative analysis of the addition of empagliflozin versus doubling the furosemide dose in decompensated heart failure.
Authors: Polat F; Department of Cardiology, Health Sciences University Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey. drfuatpolat@gmail.com., Kaya Z; Department of Cardiology, ASV Yaşam Hospital, Antalya, Turkey., Süleymanoğlu C; Department of Cardiology, Osmaniye State Hospital, Osmaniye, Turkey.
Source: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2025 Oct; Vol. 39 (5), pp. 1033-1043. Date of Electronic Publication: 2024 Jun 12.
Publication Type: Journal Article; Comparative Study; Randomized Controlled Trial
Journal Info: Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7241 (Electronic) Linking ISSN: 09203206 NLM ISO Abbreviation: Cardiovasc Drugs Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38864970
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Comparative analysis of the addition of empagliflozin versus doubling the furosemide dose in decompensated heart failure.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Polat+F%22">Polat F</searchLink>; Department of Cardiology, Health Sciences University Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey. drfuatpolat@gmail.com.<br /><searchLink fieldCode="AU" term="%22Kaya+Z%22">Kaya Z</searchLink>; Department of Cardiology, ASV Yaşam Hospital, Antalya, Turkey.<br /><searchLink fieldCode="AU" term="%22Süleymanoğlu+C%22">Süleymanoğlu C</searchLink>; Department of Cardiology, Osmaniye State Hospital, Osmaniye, Turkey.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228712220%22">Cardiovascular drugs and therapy</searchLink> [Cardiovasc Drugs Ther] 2025 Oct; Vol. 39 (5), pp. 1033-1043. <i>Date of Electronic Publication: </i>2024 Jun 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic+For+The+International+Society+For+Cardiovascular+Pharmacotherapy%22">Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8712220 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209203206%22">09203206 </searchLink><i>NLM ISO Abbreviation: </i>Cardiovasc Drugs Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38864970
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10557-024-07593-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1033
    Titles:
      – TitleFull: Comparative analysis of the addition of empagliflozin versus doubling the furosemide dose in decompensated heart failure.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Polat F
      – PersonEntity:
          Name:
            NameFull: Kaya Z
      – PersonEntity:
          Name:
            NameFull: Süleymanoğlu C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2025 Oct
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7241
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Cardiovascular drugs and therapy
              Type: main
ResultId 1